(Q36968695)

17 August 2017

Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level? (English)

1 reference

autosomal dominant polycystic kidney disease

17 August 2017

1 reference

autosomal dominant polycystic kidney

inferred from title

1 reference

G Canaud

1

1 reference

17 August 2017

B Knebelmann

2

1 reference

17 August 2017

P C Harris

3

1 reference

17 August 2017

F Vrtovsnik

4

1 reference

17 August 2017

J-M Correas

5

1 reference

17 August 2017

N Pallet

6

1 reference

17 August 2017

C M Heyer

7

1 reference

17 August 2017

E Letavernier

8

1 reference

17 August 2017

F Bienaimé

9

1 reference

17 August 2017

E Thervet

10

1 reference

17 August 2017

F Martinez

11

1 reference

17 August 2017

F Terzi

12

1 reference

17 August 2017

C Legendre

13

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

American Journal of Transplantation

17 August 2017

1 reference

17 August 2017

10

1 reference

17 August 2017

7

1 reference

17 August 2017

1701-1706

1 reference

A mitotic transcriptional switch in polycystic kidney disease

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Measured GFR as a confirmatory test for estimated GFR.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Autosomal dominant polycystic kidney disease: the last 3 years

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Polycystic kidney disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Sirolimus reduces polycystic liver volume in ADPKD patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

TOR signaling in growth and metabolism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Transplantation of a cadaveric polycystic kidney in a patient with autosomal dominant polycystic kidney disease: long-term outcome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Reduced exposure to calcineurin inhibitors in renal transplantation

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3697013

Development of polycystic disease in a kidney 10 years after transplantation

4 September 2018

1 reference

12 December 2020

Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease

1 reference

12 December 2020

Polycystic kidney patient as a cadaveric donor: is it appropriate?

1 reference

12 December 2020

Polycystic kidney disease

1 reference

12 December 2020

Transplant of a polycystic kidney because of organ shortage

1 reference

12 December 2020

Successful use of cadaver kidneys from diabetic donors for transplantation

1 reference

12 December 2020

The polycystic kidney donor

1 reference

12 December 2020

Volume progression in polycystic kidney disease

1 reference

12 December 2020

Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

High sirolimus levels may induce focal segmental glomerulosclerosis de novo

1 reference

12 December 2020

10.1111/J.1600-6143.2010.03152.X

Identifiers

DOI

1 reference

17 August 2017

1 reference

17 August 2017

1 reference